Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Could TSHA stock gain momentum as Taysha advances TSHA-102 toward a Rett syndrome BLA? Find out how Taysha’s TSHA-102 Rett syndrome update could affect TSHA stock, BLA planning and rare disease gene therapy competition today! bySoujanya RaviJune 24, 2026